Biocryst Pharmaceuticals Inc.
Laurent Vernillet, PharmD, PhD, FCP, is the Global Head of the Cinical Pharmacology group at Biocryst Pharmaceuticals Inc. Prior to joining Biocryst, Dr. Vernillet had different positions in Drug Metablism and Pharmacokinetics and Clinical Pharmacology at Intercept, SK Life Science, Boehringer-Ingelheim, Vertex Pharmaceuticals, Genentech/Roche, TAP Pharmaceuticals, Eli-Lilly, Sanofi and Novartis. Dr Vernillet spent more than twenty five years as a Project Team Leader, Clinical Program Leader, Head of Clinical Pharmacology and Preclinical Pharmacology Department developing both small molecules and biologics from Research to submission. He contributed to multiple NDA, MAA and J-NDA submisions across different therapeutic areas (oncology, immunology, rheumatology, metabolism, respiratory, CNS and virology). Dr. Vernillet received his Master’s degree in Pharmacokinetics from Paris XI University in France, his PharmD degree and Doctorate degree in Experimemntal and Clinical Pharmacology from Paris V University in France.
Tuesday, September 12, 2023
3:30 PM - 5:00 PM PT
Disclosure(s): No financial relationships to disclose